Ganli Pharmaceutical funding history / development milestones

IPO上市,主板

2020.06.29,上交所

B轮,3.36亿人民币

天使轮,1亿人民币

2010.05.19, 启明创投

Note: collected from public online reports, for reference only.

People who follow Ganli Pharmaceutical also follow

Ganli Pharmaceutical Competitors (Similar Companies)

生物制品 原料药 生物制药 胰岛素
“To develop high-quality biologics that are accessible and affordable f”
“Pharmaceutical preparations and medical devices”
“Dedicated to the research and development of molecularly targeted drug”
“一家拥有70余年辉煌历史的制药企业”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“A leader in China's pharmaceutical and healthcare market”
“Large-scale pharmaceutical distribution enterprise”
“Promoting human health”
“One of the leading enterprises in the pharmaceutical industry”
“Research, development, and production of anti-tumor and surgical medic”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Large pharmaceutical and health industry group”
“Although the processing is complicated, we dare not save labor; althou”
“Promoting Chinese traditional health culture and rejuvenating national”